5Martin E,Romeijn SG,VitCrhoef JC,et al.Nassal absorption of dihydroergotamine from liquid and powder formulations in rabbits[J].J Pharm Sci,1997,86(7):802-807.
6Pomerleau OF,Flessland KA,Pomerlean CS,et al.Controlled dosing of nicotine via an intranasalnicotine aerosol delivery device[J].Psychopharmacology,1992,108(4):519-526.
8Ishikawa P,Murano M,Hiraishi M,et al.Insoluhle powder formulation as an effective nasal drug delivery system[J].Pharm Res,2002,19(8):1097-l104.
9Morimoto K,Yamaguichi H,Iwakura Y,et al.Effect of ciscous hualuronatesodium solutions on nasal absorption of vasopressin and an analogue[J].Pharm Res,1991,8(4):471-474.
10Lim ST,Martin GP,Berry DJ,et al.Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microsphere of hyaluronic acid and chitosan[J].J Controlled Release,2000,66(2-3):281-292.
